
Jane E Carleton MD
Assistant Professor, Medicine, Hofstra North Shore-LIJ
Join to view full profile
450 Lakeville RoadNew Hyde Park, NY 11042
Phone+1 516-734-8966
Fax+1 516-734-7687
Dr. Carleton is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jane Carleton is a medical oncologist based in New Hyde Park, NY, specializing in breast cancer. She completed her fellowship in Hematology and Medical Oncology and residency in Internal Medicine at Tufts Medical Center after obtaining her medical degree from the University of Massachusetts Medical School. Since 2002, she has been practicing at Northwell Health Physician Partners Internal Medicine at Lake Success. Dr. Carleton has contributed to the field through several publications, including work on breast cancer and lung cancer, and has been involved in clinical trials related to small-cell lung cancer. She has received CMS Meaningful Use Stage 1 Certification from Allscripts.
Clinical Expertise
- Hematologic oncology
Education & Training
Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1994 - 1998
Tufts Medical CenterResidency, Internal Medicine, 1991 - 1994
University of Massachusetts Medical SchoolClass of 1991
Certifications & Licensure
NY State Medical License 2001 - 2027
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR (Complete), Allscripts, 2016-2017
- CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR, Allscripts, 2016-2017
Clinical Trials
Publications & Presentations
PubMed
- 14 citationsFamily-building After Breast Cancer: Considering the Effect on Adherence to Adjuvant Endocrine TherapyCatherine Benedict, Bridgette Thom, Eleonora Teplinsky, Jane Carleton, Joanne Frankel Kelvin
Clinical Breast Cancer. 2017-06-01 - 388 citationsPhase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124Primo N. Lara, Ronald B. Natale, John Crowley, Heinz-Josef Lenz, Mary W. Redman
Journal of Clinical Oncology. 2009-05-20
Press Mentions
- Clinical Trials Saving Breast Cancer Patient Lives: A Long Island New York StoryOctober 28th, 2020
- Breast Cancer Clinical Trials at Long Island Hospitals Offering New HopeOctober 27th, 2020
Greater Treatment Options for Breast Cancer PatientsOctober 6th, 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









